News
Article
Author(s):
The Virginia Cannabis Control Authority reported data on medical cannabis sales and most popular products for July to August 2025.
Image | adobe.stock/colnihko
Virginia recently launched a seed-to-sale tracking system for medical cannabis sales, and the latest results are in. On September 16, the Virginia Cannabis Control Authority (CCA) published data on the sales and plans for the future (1).
As listed in the news release, data from July and August 2025 included:
The data also tracked the most commonly chosen types of products patients choose:
Only licensed medical cannabis companies can use the sed-to-sale system, enhancing safety by ensuring only tested and regulated products reach patients.
“This system gives us a clear, real-time view of medical cannabis across Virginia,” said Jamie Patten, Acting Head and Chief Administrative Officer of the CCA, in the September 16 press release. “We can see which products are popular, track plant growth, and understand sales trends. That information helps us protect patients, prevent illegal products from entering the market, and make smart decisions for the program’s future.”
The CCA also plans on producing a public dashboard for additional transparency in the program.
The seed-to-sale system is operated by Metrc, a cannabis retail and regulation technology company in use in several states. In California, Metrc recently added a new feature allowing consumers direct access to testing, safety, and recalls of products by scanning the QR code on packages (2). Earlier this year, Metrc also signed a contract with the US Virgin Islands for the track-and-trace platform in order to support the regulation of its medical and recreational cannabis markets (3).
Earlier this month, a new online portal from the CCA enhanced patients’ access to their medical cannabis certification, allowing for viewing or printing a copy to take to dispensaries (4). Practitioners are also able to print certifications. The new portal is intended to be and offer protections for information and against fraud, offering a simpler process overall for patients.
“Our new CCA Portal is a major step forward for Virginia’s medical cannabis program,” stated Jamie Patten, Acting Head and Chief Administrative Officer of the CCA, in the news release. “It’s safer, faster, and easier to use, and it helps us better protect patient information while supporting the integrity of the program.”
The portal is also mobile-friendly, compatible with phones, tables, and computers.
In May 2025, Governor Glenn Youngkin had vetoed House Bill 1989, affecting medical cannabis delivery locations and labeling requirements (5). Medical cannabis deliveries to patients had been taking place in the state since 2020.
In his veto statement, the Governor expressed concerns about the negative effects of expanded delivery locations. “While accurate labeling is essential to ensure patients receive consistent and safe medical cannabis, this bill would codify the ability to deliver medical cannabis to commercial businesses and temporary residences, raising public safety and regulatory concerns,” he stated. “Permitting deliveries to businesses—including locations where substance abuse, gambling, or other high-risk activities may occur—creates unnecessary risks for diversion, theft, and unintended access by minors.”
Medical cannabis advocates argued that without the new locations, patients must instead have their medications delivered to their residences during limited delivery times.
Between March 2024 and March 2025, Governor Youngkin had vetoed other bills related to cannabis, related to resentencing relief, parental rights, and state-regulated standards for licenses and sales of recreational cannabis.
References
Unlock the latest breakthroughs in cannabis science—subscribe now to get expert insights, research, and industry updates delivered to your inbox.